An Injectable Bone Mesenchymal Stem Cells-derived Exosome/lyophilized Concentrated Growth Factor Hybrid Hydrogel Promotes Bone Regeneration
- 25 June 2025
- journal article
- letter
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 21 (7) , 2322-2323
Abstract
No abstract availableFunding Information
- Jinan Clinical Medical Science and Technology Innovation Program (No.202225010, No.202225010, No.202225010, No.202225010)
- Science and Technology Development Program of Jinan Municipal Health Commission (No.2021-1-45, No.2021-1-45, No.2021-1-45, No.2021-1-45)
This publication has 5 references indexed in Scilit:
- Engineering homologous platelet-rich plasma, platelet-rich plasma-derived exosomes, and mesenchymal stem cell-derived exosomes-based dual-crosslinked hydrogels as bioactive diabetic wound dressingsBioactive Materials, 2023
- Lyophilized Platelet-Rich Fibrin Exudate-Loaded Carboxymethyl Chitosan/GelMA Hydrogel for Efficient Bone Defect RepairACS Applied Materials & Interfaces, 2023
- An Injectable Integration of Autologous Bioactive Concentrated Growth Factor and Gelatin Methacrylate Hydrogel with Efficient Growth Factor Release and 3D Spatial Structure for Accelerated Wound HealingMacromolecular Bioscience, 2023
- Exosome-functionalized magnesium-organic framework-based scaffolds with osteogenic, angiogenic and anti-inflammatory properties for accelerated bone regenerationBioactive Materials, 2022
- Bone allograftsThe Journal of Bone and Joint Surgery. British volume, 2007